A facile approach to functionalize cell membrane-coated nanoparticles

Theranostics

Volumn 6, Issue 7, 2016, Pages 1012-1022

  Zhou, Hao ^a   Fan, Zhiyuan ^a   Lemons, Pelin K ^a   Cheng, Hao ^a,b  

^a Drexel University   (United States)

^b DREXEL UNIVERSITY   (United States)

Author keywords

Biomimetics; Drug delivery; Extracellular matrix; Lymph nodes; Tumor penetration

Indexed keywords

CELL MEMBRANE COATED NANOPARTICLE; ESTER; HYALURONIC ACID; MACROGOL; NANOPARTICLE; RECOMBINANT HYALURONIDASE; RED BLOOD CELL MEMBRANE COATED NANOPARTICLE; SUCCINIMIDYL [(N MALEIMIDOPROPIONAMIDO)POLYETHYLENEGLYCOL] ESTER; UNCLASSIFIED DRUG; DRUG CARRIER; HYALURONOGLUCOSAMINIDASE; IMMOBILIZED ENZYME; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; CIRCULATION TIME; CONTROLLED STUDY; DIFFUSION; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; EXTRACELLULAR MATRIX; FEMALE; INTERNALIZATION; MOUSE; NANOFABRICATION; NONHUMAN; PROSTATE CANCER CELL LINE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; TUMOR CELL CULTURE;

CELL MEMBRANE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENZYMES, IMMOBILIZED; HUMANS; HYALURONOGLUCOSAMINIDASE; NANOPARTICLES; RECOMBINANT PROTEINS; TUMOR CELLS, CULTURED;

EID: 84979633293     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.15095     Document Type: Article

References (41)

1. Hu CMJ, Zhang L, Aryal S, Cheung C, Fang RH, Zhang LF. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108: 10980-5.
2. Hu CMJ, Fang RH, Copp J, Luk BT, Zhang LF. A biomimetic nanosponge that absorbs pore-forming toxins. Nat Nanotechnol. 2013; 8: 336-40.
3. Hu CMJ, Fang RH, Luk BT, Zhang LF. Nanoparticle-detained toxins for safe and effective vaccination. Nat Nanotechnol. 2013; 8: 933-8.
4. Li LL, Xu JH, Qi GB, Zhao XZ, Yu FQ, Wang H. Core-Shell Supramolecular Gelatin Nanoparticles for Adaptive and "On-Demand" Antibiotic Delivery. ACS Nano. 2014; 8: 4975-83.
5. Guo YY, Wang D, Song QL, Wu TT, Zhuang XT, Bao YL, et al. Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma. ACS Nano. 2015; 9: 6918-33.
6. Fan ZY, Zhou H, Li PY, Speer JE, Cheng H. Structural elucidation of cell membrane-derived nanoparticles using molecular probes. Journal of Materials Chemistry B. 2014; 2: 8231-8.
7. Tan SW, Wu TT, Zhang D, Zhang ZP. Cell or cell membrane-based drug delivery systems. Theranostics. 2015; 5: 863-81.
8. Gao WW, Zhang LF. Engineering red-blood-cell-membrane-coated nanoparticles for broad biomedical applications. Aiche Journal. 2015; 61: 738-46.
9. Oldenborg PA, Zheleznyak A, Fang YF, Lagenaur CF, Gresham HD, Lindberg FP. Role of CD47 as a marker of self on red blood cells. Science. 2000; 288: 2051-4.
10. Parodi A, Quattrocchi N, van de Ven AL, Chiappini C, Evangelopoulos M, Martinez JO, et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat Nanotechnol. 2013; 8: 61-8.
11. Hu C-MJ, Fang RH, Wang K-C, Luk BT, Thamphiwatana S, Dehaini D, et al. Nanoparticle biointerfacing by platelet membrane cloaking. Nature. 2015; 526: 118-21.
12. Hu Q, Sun W, Qian C, Wang C, Bomba HN, Gu Z. Anticancer Platelet-Mimicking Nanovehicles. Advanced Materials. 2015; 27: 7043-50.
13. Fang RH, Hu CMJ, Luk BT, Gao WW, Copp JA, Tai YY, et al. Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery. Nano Lett. 2014; 14: 2181-8.
14. Gao WW, Fang RH, Thamphiwatana S, Luk BT, Li JM, Angsantikul P, et al. Modulating Antibacterial Immunity via Bacterial Membrane-Coated Nanoparticles. Nano Lett. 2015; 15: 1403-9.
15. Patel JM, Vartabedian VF, Bozeman EN, Caoyonan BE, Srivatsan S, Pack CD, et al. Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growth. Biomaterials. 2016; 74: 231-44.
16. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nature Reviews Genetics. 2003; 4: 346-58.
17. Hwang WY, Fu YF, Reyon D, Maeder ML, Tsai SQ, Sander JD, et al. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol. 2013; 31: 227-9.
18. Wang Q, Cheng H, Peng H, Zhou H, Li PY, Langer R. Non-genetic engineering of cells for drug delivery and cell-based therapy. Advanced Drug Delivery Reviews. 2015; 91: 125-40.
19. Luk BT, Hu CMJ, Fang RNH, Dehaini D, Carpenter C, Gao WW, et al. Interfacial interactions between natural RBC membranes and synthetic polymeric nanoparticles. Nanoscale. 2014; 6: 2730-7.
20. Chung HA, Kato K, Itoh C, Ohhashi S, Nagamune T. Casual cell surface remodeling using biocompatible lipid-poly(ethylene glycol)(n): Development of stealth cells and monitoring of cell membrane behavior in serum-supplemented conditions. Journal of Biomedical Materials Research Part A. 2004; 70A: 179-85.
21. Hymel D, Peterson BR. Synthetic cell surface receptors for delivery of therapeutics and probes. Advanced Drug Delivery Reviews. 2012; 64: 797-810.
22. Fang RNH, Hu CMJ, Chen KNH, Luk BT, Carpenter CW, Gao WW, et al. Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. Nanoscale. 2013; 5: 8884-8.
23. Bell GI. Models for the specific adhesion of cells to cells. Science (New York, NY). 1978; 200: 618-27.
24. Chinol M, Casalini P, Maggiolo M, Canevari S, Omodeo ES, Caliceti P, et al. Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity. Br J Cancer. 1998; 78: 189-97.
25. Smarr CB, Hsu CL, Byrne AJ, Miller SD, Bryce PJ. Antigen-Fixed Leukocytes Tolerize Th2 Responses in Mouse Models of Allergy. J Immunol. 2011; 187: 5090-8.
26. Cheng H, Byrska-Bishop M, Zhang CT, Kastrup CJ, Hwang NS, Tai AK, et al. Stem cell membrane engineering for cell rolling using peptide conjugation and tuning of cell-selectin interaction kinetics. Biomaterials. 2012; 33: 5004-12.
27. Turley DM, Miller SD. Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis. J Immunol. 2007; 178: 2212-20.
28. Standley SM, Toft DJ, Cheng H, Soukasene S, Chen J, Raja SM, et al. Induction of Cancer Cell Death by Self-assembling Nanostructures Incorporating a Cytotoxic Peptide. Cancer Res. 2010; 70: 3020-6.
29. Jiang P, Li XM, Thompson CB, Huang ZD, Araiza F, Osgood R, et al. Effective Targeting of the Tumor Microenvironment for Cancer Therapy. Anticancer Res. 2012; 32: 1203-12.
30. Provenzano PP, Cuevas C, Chang AE, Goel VK, Von HoffDD, Hingorani SR. Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma. Cancer Cell. 2012; 21: 418-29.
31. Aaltomaa S, Lipponen P, Tammi R, Tammi M, Viitanen J, Kankkunen JP, et al. Strong stromal hyaluronan expression is associated with PSA recurrence in local prostate cancer. Urologia Internationalis. 2002; 69: 266-72.
32. Auvinen P, Tammi R, Kosma VM, Sironen R, Soini Y, Mannermaa A, et al. Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer. International Journal of Cancer. 2013; 132: 531-9.
33. Whatcott CJ, Han H, Posner RG, Hostetter G, Von HoffDD. Targeting the Tumor Microenvironment in Cancer: why Hyaluronidase Deserves a second Look. Cancer Discovery. 2011; 1: 291-6.
34. Bot PT, Hoefer IE, Piek JJ, Pasterkamp G. Hyaluronic acid: Targeting immune modulatory components of the extracellular matrix in atherosclerosis. Curr Med Chem. 2008; 15: 786-91.
35. Sadowitz B, Seymour K, Gahtan V, Maier KG. The Role of Hyaluronic Acid in Atherosclerosis and Intimal Hyperplasia. J Surg Res. 2012; 173: E63-E72.
36. Cheng J, Teply BA, SherifiI, Sung J, Luther G, Gu FX, et al. Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials. 2007; 28: 869-76.
37. Frost GI, Stern R. A microtiter-based assay for hyaluronidase activity not requiring specialized reagents. Analytical Biochemistry. 1997; 251: 263-9.
38. Wong C, Stylianopoulos T, Cui JA, Martin J, Chauhan VP, Jiang W, et al. Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108: 2426-31.
39. Singha NC, Nekoroski T, Zhao CM, Symons R, Jiang P, Frost GI, et al. Tumor-Associated Hyaluronan Limits Efficacy of Monoclonal Antibody Therapy. Mol Cancer Ther. 2015; 14: 523-32.
40. Thompson CB, Shepard HM, O'Connor PM, Kadhim S, Jiang P, Osgood RJ, et al. Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models. Mol Cancer Ther. 2010; 9: 3052-64.
41. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, et al. Ceramide triggers budding of exosome vesicles into multivesicular Endosomes. Science. 2008; 319: 1244-7.